Empro Group Inc. (EMPG)
Healthcare · NCM
Fundamentals
Valuation and ratings
Empro Group Inc. trades at USD17.36, which is 60% above the USD6.94 our discounted cash flow model puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 67 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 192.9 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
About Empro Group Inc.
Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company offers eyebrow pencils, skincare and antibacterial moisturizing mist products, surgical face masks, nitrile gloves, test kits, lips natural recovery cream, and black diamond eyeliners under the Empro, Premio, SpaceLift, and Mios brands. It sells its products through retails stores and online retail. The company was founded in 2004 and is based in Shah Alam, Malaysia.
EMPG passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is Empro Group Inc. (EMPG) undervalued?
Against our discounted cash flow estimate of USD6.94, EMPG at USD17.36 is 60% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
What is EMPG's P/E ratio?
EMPG trades at 192.9 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
The full research page for EMPG, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.